UG

Urmil Girishbhai Shah

Director Director DIN 00271972
DIN 00271972 First appointment Mar 2002 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2002
Shareholding value •••• Premium profile

About Urmil Girishbhai Shah

Data last updated:

Urmil Girishbhai Shah was a Director at Cims Hospital Private Limited (2002–2021) and Director at Clinical Care Consultants Private Limited (2010–2019). The companies operate in Healthcare.

DIN 00271972
Primary Designation Director
Industry Healthcare
First Appointment 31 Mar 2002

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cims Hospital Private Limited U85110GJ2001PTC039962
Director31 Mar 20022001₹292 Cr (FY 2023)Amalgamated
Director29 Apr 20102010₹19,543 (FY 2017)Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cims Hospital Private Limited
Clinical Care Consultants Private Limited
Premium access

Shareholding and investment profile for Urmil Girishbhai Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Urmil Girishbhai Shah

Urmil Girishbhai Shah was first appointed on 31 Mar 2002 as Director at Cims Hospital Private Limited. The most recent appointment on record is 29 Apr 2010 at Clinical Care Consultants Private Limited.

Urmil Girishbhai Shah held 2 earlier board appointments: Cims Hospital Private Limited (Director, 31 Mar 2002 to 27 Oct 2021); Clinical Care Consultants Private Limited (Director, 29 Apr 2010 to 09 Apr 2019).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available